Skip to main content
Benjamin Peterson, MD, Cardiology, Edgewood, KY

BenjaminEvansPetersonMDMPH

Cardiology Edgewood, KY

Interventional Cardiology

Interventional cardiologist Structural heart program Medical Director Heart and Vascular Research Institute

Dr. Peterson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Peterson's full profile

Already have an account?

  • Office

    711 Medical Village Dr
    Edgewood, KY 41017
    Phone+1 859-287-3045
    Fax+1 859-578-3800

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2016 - 2019
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 2013 - 2016
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2013

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2022 - 2025
  • KY State Medical License
    KY State Medical License 2022 - 2025
  • MA State Medical License
    MA State Medical License 2016 - 2023
  • RI State Medical License
    RI State Medical License 2021 - 2022
  • NC State Medical License
    NC State Medical License 2013 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease
  • American Board of Internal Medicine Interventional Cardiology

Publications & Presentations

PubMed

Press Mentions

  • Addition of Icosapent Ethyl Cuts CV Risk in Patients with Prior PCI
    Addition of Icosapent Ethyl Cuts CV Risk in Patients with Prior PCIMarch 24th, 2022
  • Amarin’s Vascepa Shows Lower Risk of Fatal CV Events in REDUCE-IT Prior PCI Post Hoc Subanalysis
    Amarin’s Vascepa Shows Lower Risk of Fatal CV Events in REDUCE-IT Prior PCI Post Hoc SubanalysisMarch 10th, 2022
  • REDUCE-IT: Significant Reduction in Coronary Revascularizations with Icosapent Ethyl
    REDUCE-IT: Significant Reduction in Coronary Revascularizations with Icosapent EthylMay 15th, 2020